Oasmia Pharmaceutical AB. Daily Stock Analysis

Daily Stock Analysis, OASM, Oasmia Pharmaceutical AB, priceseries

Oasmia Pharmaceutical AB. Daily Stock Analysis
Stock Information
Open
1.61
Close
1.59
High
1.61
Low
1.59
Previous Close
1.60
Daily Price Gain
-0.02
YTD High
5.70
YTD High Date
Sep 26, 2018
YTD Low
0.80
YTD Low Date
Nov 9, 2017
YTD Price Change
-2.31
YTD Gain
-59.31%
52 Week High
5.70
52 Week High Date
Sep 26, 2018
52 Week Low
0.80
52 Week Low Date
Nov 9, 2017
52 Week Price Change
-2.31
52 Week Gain
-59.31%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 24. 2017
1.90
Mar 28. 2017
2.02
2 Trading Days
6.58%
Link
LONG
Apr 19. 2017
2.10
Apr 20. 2017
2.24
1 Trading Days
6.67%
Link
LONG
Jan 25. 2018
1.25
Feb 5. 2018
1.40
7 Trading Days
11.64%
Link
LONG
Apr 5. 2018
1.35
Apr 27. 2018
1.62
16 Trading Days
20.14%
Link
LONG
Jul 10. 2018
1.33
Jul 20. 2018
1.44
8 Trading Days
8.06%
Link
LONG
Aug 28. 2018
1.88
Sep 14. 2018
2.32
12 Trading Days
23.57%
Link
LONG
Sep 21. 2018
3.45
Oct 2. 2018
3.74
7 Trading Days
8.41%
Link
LONG
Oct 8. 2018
3.82
Oct 15. 2018
4.05
5 Trading Days
5.98%
Link
LONG
Nov 1. 2018
4.16
Nov 19. 2018
4.63
12 Trading Days
11.22%
Link
LONG
Feb 22. 2019
2.44
Mar 1. 2019
2.62
5 Trading Days
7.11%
Link
Company Information
Stock Symbol
OASM
Exchange
NasdaqCM
Company URL
http://www.oasmia.com
Company Phone
011 46 18 50 54 40
CEO
Mikael Asp
Headquarters
-
Business Address
VALLONGATAN 1, UPPSALA, SWEDEN 752 28
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001607245
About

Oasmia Pharmaceutical AB is engaged in reaserch and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. Its portfolio includes Paclical, Doxophos, Docecal, and OAS-19 for human health; and Paccal Vet and Doxophos Vet for animal health. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Description

Developing formulations of widely-used cancer drugs for humans and dogs.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading